Abstract: An array of absorbent article packages for multiple baby stages of development displayed via a merchandise display system may comprise multiple packages. Each package may comprise articles having absorbent article configurations appropriate for the stage of development of an infant, newborn, or toddler. Each article or package may also comprise indicia representative of the appropriate stage of development of the infant, newborn, or toddler. And, absorbent article configurations may differ between packages having overlapping size ranges.

Abstract: An absorbent article including features facilitating toilet training of a wearer is provided. The article includes at least a first appearing graphic that changes from an initial, less visible state to a subsequent, more visible state in the absence of wetness, thereby to provide positive encouragement to a child during toilet training. The appearing graphic becomes less visible if subjected to liquid. A wetness sensation member may also be provided to give tactile, negative sensation to the child, thereby giving feedback received by at least two different senses. Additionally or alternatively, a second appearing graphic, different from the first appearing graphic, may be provided to increase a child's interest in the toilet training process. The first and second appearing graphics may become visible at different times, thereby providing a sequential or spaced reveal of the image.

Abstract: A CT scanner apparatus includes an X-ray source mounted on a gantry of the CT scanner apparatus and configured to emit X-rays, and at least one magnetic field gradient circuit. The at least one magnetic field gradient circuit and the X-ray source rotate together. The CT scanner apparatus also includes a CT detector mounted on the gantry in fixed orbital opposition to the X-ray source. The CT detector is configured to detect the X-rays, wherein the CT detector and the X-ray source are configured to rotate along a first orbital path. The CT scanner apparatus also includes an array of fixed PCD assemblies arranged in a ring inside the first orbital path. Each PCD assembly is configured to rotatably actuate about a gantry support from a first position to a second position to reduce blockage of emitted X-rays when the magnetic field gradient circuit rotates within a predetermined distance of the PCD assembly.

Abstract: An array of absorbent article packages for multiple baby stages of development displayed via a merchandise display system may comprise multiple packages. Each package may comprise articles having absorbent article configurations appropriate for the stage of development of an infant, newborn, or toddler. Each package may also comprise indicia representative of the appropriate stage of development of the infant, newborn, or toddler. And, absorbent article configurations may differ between packages having overlapping size ranges.

Abstract: A method of manufacturing customized absorbent hygiene articles, the articles comprising an absorbent core, a topsheet, and a backsheet, the method comprising the steps of: (a) providing a set of choices designed to allow a consumer to specify the customized article; (b) receiving a selection from the consumer among the set of choices; (c) manufacturing the customized article; and (d) distributing the customized article to the consumer; wherein the set of choices is selected from: the material specification of the topsheet and/or the backsheet; the absorbent capacity, absorbency profile, and/or shape of the absorbent core; the material specification and/or design of leg cuffs, of waist bands or waist elastics, of fastening members or elastic side panels, of a raised barrier for fecal control; selection of a lotion applied to the topsheet or to the leg cuff; and combinations thereof

Abstract: An absorbent article including features facilitating toilet training of a wearer is provided. The article includes at least a first appearing graphic that changes from an initial, less visible state to a subsequent, more visible state in the absence of wetness, thereby to provide positive encouragement to a child during toilet training. The appearing graphic becomes less visible if subjected to liquid. A wetness sensation member may also be provided to give tactile, negative sensation to the child, thereby giving feedback received by at least two different senses. Additionally or alternatively, a second appearing graphic, different from the first appearing graphic, may be provided to increase a child's interest in the toilet training process. The first and second appearing graphics may become visible at different times, thereby providing a sequential or spaced reveal of the image.

Abstract: The present invention relates to a combination comprising (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide, or a pharmaceutically acceptable salt thereof, hereafter “Compound (I)”, and a taxane. Taxanes include established cancer drugs such as docetaxel (Taxotere™) and paclitaxel (Taxol™). Such combinations may be useful in the treatment or prophylaxis of cancer. The invention also relates to a pharmaceutical composition comprising such Compound (I) and a taxane. The invention further relates to a method of treatment comprising the simultaneous, sequential or separate administration of Compound (I) and a taxane, to warm-blooded animal, such as man. The invention also relates to a kit comprising Compound (I) and a taxane, optionally with instructions for use.

Abstract: A displaceable speaker assembly for a vehicle includes a housing, a speaker array rotatably coupled to the housing and including a plurality of electro-acoustic transducers (e.g., twiddlers), a drive unit coupled to the housing, and a lever assembly coupling the drive unit to the speaker array. The drive unit is operable to drive motion of the lever assembly, which, in turn, drives rotation of the speaker array relative to the housing.

Abstract: An absorbent article comprising a raised barrier is provided. The raised barrier extends into a front waist region, a crotch region, and a back waist region of the absorbent article.

Abstract: Aspects of the present disclosure involve a disposable absorbent article configured to be placed on the body of a wearer to mimic swaddling characteristics. The disposable absorbent article may include a chassis having a tuck flap and two ears or side panels. The two ears extend in opposing lateral directions from a first waist region, and the tuck flap extends in a longitudinal direction from a second waist region. Other chassis embodiments may include two additional ears extending in opposing lateral directions from the second waist region. The chassis is adapted to fit a wearer by wrapping the two ears around a wearer's waist, passing the second waist region between a wearer's legs, and folding and/or tucking the tuck flap over the ears. Embodiments of the chassis may be constructed with manually formed or pre-formed tuck flaps that may also be stretchable.

Abstract: The present invention relates to a combination comprising (5)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide, or a pharmaceutically acceptable salt thereof, hereafter “Compound (I)”, and a taxane. Taxanes include established cancer drugs such as docetaxel (Taxotere™) and paclitaxel (Taxol™). Such combinations may be useful in the treatment or prophylaxis of cancer. The invention also relates to a pharmaceutical composition comprising such Compound (I) and a taxane. The invention further relates to a method of treatment comprising the simultaneous, sequential or separate administration of Compound (I) and a taxane, to warm-blooded animal, such as man. The invention also relates to a kit comprising Compound (I) and a taxane, optionally with instructions for use.

Abstract: The present invention relates to a combination comprising AZD5363, or a pharmaceutically acceptable salt thereof, and at least one androgen receptor signalling modulator selected from MDV-3100 (also known as enzalutamide), AZD3514, abiraterone (or an ester prodrug thereof: e.g. abiraterone acetate), and bicalutamide; or a pharmaceutically acceptable salt thereof. Each of these combinations may be useful in the treatment of cancer. The invention also relates to pharmaceutical compositions comprising such combinations, and further relates to methods of treatment comprising the simultaneous, sequential or separate administration of AZD5363, or a pharmaceutically acceptable salt thereof, with at least one androgen receptor signalling modulator as described above, to warm-blooded animal, such as a human for the treatment of cancer. The invention also relates to a kit comprising such combinations.

Abstract: A computed tomography (CT) imaging apparatus includes a radiation source to emit X-rays while rotating in a predetermined trajectory; a plurality of detectors arranged in a circular ring and configured to detect the emitted X-rays; and processing circuitry to cause the radiation source to scan an object, and cause a subset of the detectors nearest to the radiation source to move in a direction intersecting with a plane of the predetermined trajectory of the radiation source in accordance with a determined location of the radiation source.

Abstract: The wearable ground blind described herein advantageously obscures the silhouette of the hunter, blocks the hunter's smell, muffles noise, and protects the hunter from the weather.

Abstract: The present invention relates to the use of combinations comprising 8-[(1R)-1-(3,5-difluorophenylamino)ethyl]-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide or a pharmaceutically acceptable salt thereof and a taxane in the treatment or prophylaxis of cancer; pharmaceutical compositions comprising Compound [I] (or a pharmaceutically acceptable salt thereof) and a taxane; kits comprising Compound [I] or a pharmaceutically acceptable salt thereof and a taxane, optionally with instructions for use; and methods of treatment comprising the simultaneous, sequential or separate administration of Compound [I] or a pharmaceutically acceptable salt thereof and a taxane to warm-blooded animal, such as man.

Abstract: The present disclosure is directed, in part, to an absorbent article comprising a liquid permeable topsheet, a liquid impermeable backsheet, and an absorbent core positioned at least partially intermediate the liquid permeable topsheet and the liquid impermeable backsheet. The liquid permeable topsheet may comprise a flow control material. The flow control material may form an at least mostly enclosed perimeter over at least a portion of the absorbent core. The flow control material may extend outwardly from the liquid permeable topsheet and/or may penetrate a portion of the liquid permeable topsheet.

Abstract: The present disclosure is directed, in part, to an absorbent article comprising a liquid permeable topsheet, a liquid impermeable backsheet, and an absorbent core positioned at least partially intermediate the liquid permeable topsheet and the liquid impermeable backsheet. The absorbent article may comprise a substantially laterally-extending separation element defining a visual front portion and a visual back portion on a wearer-facing surface of the absorbent article. The liquid permeable topsheet may comprise a first zone in the visual front portion that comprises a first geometric treatment and a second zone in the visual back portion that comprises a second geometric treatment.

Abstract: The present disclosure is directed, in part, to an absorbent article comprising a liquid management system (LMS) and an absorbent core disposed at least partially intermediate a topsheet and a backsheet. The LMS defines one or more channels therein. The one or more channels of the LMS may at least partially overlap or not overlap with channels defined in the absorbent core.